INTRODUCTION
Since at least the early 1990s, many men who have sex with men (MSM) have chosen their sex partners, or selectively used condoms based on a partner's perceived HIV status. [1] [2] [3] This behavior, referred to as serosorting, is common among MSM. [4] [5] [6] [7] [8] [9] Data from the early 2000s suggested that serosorting was on the rise [10] [11] [12] and recent data from San Francisco MSM through 2011 9 suggest that these increases have continued.
The effect of serosorting on HIV and sexually transmitted infection (STI) risk is somewhat controversial. Mathematical models suggest that serosorting can increase or decrease a person's risk of acquiring HIV depending on the accuracy of HIV status disclosure, which largely depends on the population's HIV testing frequency. [13] [14] [15] Empiric evidence indicates that serosorting represents an intermediate level of HIV risk; it is associated with a lower risk of HIV acquisition than nonconcordant condom-less anal intercourse (NCCAI) but a higher risk than consistent condom use. 5, 10, [16] [17] [18] Serosorting may increase STI risk, but the magnitude is dependent on one's HIV status, and the type and anatomic site of STI. 12, 19, 20 Increases in serosorting have been hypothesized to explain increases in bacterial STI rates concurrent with declines in HIV incidence in some places. 19 However, whether serosorting increases or decreases population-level HIV/STI rates, depends in part, on changes in the frequency of serosorting and the behaviors it replaces.
We previously reported that serosorting among HIVnegative and HIV-positive MSM attending the Public Health-Seattle and King County sexually transmitted disease (STD) clinic increased between 2001 and 2007, and that NCCAI decreased during the same time period. 10 The extent to which these trends have continued in the subsequent 6 years-a period during which HIV testing frequency has increased 21 and antiretroviral therapy (ART) use has risen dramatically-is unclear. Further, important questions remain about the effect of serosorting on HIV and bacterial STI risk and how these risks may have changed in the last decade in light of expanding HIV prevention efforts. The goals of this study were to (1) examine trends in serosorting among Seattle MSM from 2001 to 2013, (2) evaluate the association between serosorting and HIV and bacterial STIs, and (3) determine if the HIV risk associated with serosorting has changed over time.
METHODS

Study Design and Population
This is a secondary data analysis of records from 2 sources: (1) MSM who attended the Public Health-Seattle and King County STD clinic from October 1, 2001 to December 31, 2013 and (2) MSM who attended Gay City Health Project (GCHP), a community-based organization with a publicly funded HIV/STI testing program, from February 2, 2004 to December 31, 2013. The start dates for the study reflect the dates when the collection of detailed sexual behavior information was initiated at the 2 sites. We defined MSM to be men who reported a male sex partner in the prior 12 months, and restricted analyses to men with complete sexual behavior data.
Data Collection and Measures
All data were collected as part of routine clinical care. Until October 2010, clinicians at the STD clinic conducted face-to-face interviews (FTFIs) with patients to collect information on sexual behaviors, drug use, and HIV testing history. These data were recorded on standardized paper forms and subsequently entered into the clinic's electronic medical record database. In October 2010, the STD clinic initiated a computer-assisted self-interview (CASI) system to collect these data from English-speaking patients. FTFIs continued to be conducted during this time for patients who did not speak English or were unable or unwilling to use a computer, when the computer system was not functioning, and in some instances to improve patient flow through the clinic. At GCHP, clients completed paper questionnaires that solicited information on demographics, sexual behavior, drug use, and HIV testing history (see Questionnaire, Supplemental Digital Content, http://links.lww.com/QAI/A789). FTFIs at GCHP were conducted for partner-level condom data and for any patients who did not speak English. Data were subsequently entered in GCHP's electronic database.
Sexual behavior information collected at the STD clinic and GCHP were identical. Men were asked about the gender of their sex partners, if they had insertive or receptive anal sex with partners who were HIV-positive, HIV-negative, or of unknown status, and how often they used condoms with partners (always/usually/sometimes/never), stratified by sexual role (insertive or receptive), and partner HIV status. All sexual behavior questions were asked about partners in aggregate and referenced the prior 12 months. We used these data to construct the following mutually exclusive sexual behavior categories: (1) no anal sex-men who did not report anal sex, (2) consistent condom use-men who always used condoms with anal sex partners, (3) serosorting-men who ever had condom-less anal intercourse (CAI) with HIV-concordant partners (ie, reported never, sometimes, or usually using condoms with HIV-concordant partners) and always used condoms with discordant/unknown-status partners or did not have discordant/unknown-status partners, and (4) NCCAImen who reported usually, sometimes, or never using condoms for anal sex with HIV-discordant/unknown-status partners. Because NCCAI includes several behaviors that confer different levels of HIV risk, 5, 22 we further stratified HIVnegative men who reported NCCAI into the following mutually exclusive categories: (1) insertive NCCAI-men who had insertive condom-less anal sex with HIV-positive/ unknown-status partners and did not have receptive anal sex with these partners, (2) condom sero-positioning-men who always used condoms for receptive anal sex with HIVpositive/unknown-status partners and who used condoms usually, sometimes, or never for insertive anal sex with these partners, and (3) receptive NCCAI-men who reported inconsistent or no condom use for receptive anal sex with HIV-positive/unknown-status partners.
HIV and STI Testing
HIV testing was recommended to all MSM who had not previously tested HIV positive. Rapid HIV-antibody tests were offered to MSM at high risk for HIV and other MSM at the discretion of medical providers. Our clinic defines MSM as high risk if they had any of the following risks in the prior year: (1) $10 sex partners, (2) methamphetamine or amyl nitrite use, (3) condom-less anal sex with a partner who is HIV-positive or of unknown status, or (4) a bacterial STI. We have previously associated these factors with an elevated risk of HIV acquisition. 23 We used OraQuick (OraSure Technologies Inc., Bethlehem, PA) until 2013 when we switched to INSTI (bioLytical Laboratories, British Columbia). Clinicians recommended that all patients have their blood drawn for syphilis and HIV testing, including persons tested for HIV using rapid tests. Patients who agreed to a blood draw were tested using a second-generation HIV EIA (Vironostika HIV-1 Microelisa System; bioMerieux, Durham, NC or rLAV Genetic System; Bio-Rad Laboratories, Hercules, CA) until 2010, when our laboratory replaced that test with a third-generation EIA (Genetic Systems HIV1/2 Plus O EIA; Biorad Laboratories, Redmond, WA). We performed pooled HIV RNA testing on all MSM who agreed to a blood draw beginning in 2003 at the STD clinic and 2006 at GCHP. We have previously described our laboratory testing procedures. [24] [25] [26] [27] Urethral specimens (swab or urine) for gonorrhea and chlamydia culture or nucleic acid amplification testing (NAAT) were obtained from STD clinic patients with signs/symptoms of urethritis or who reported exposure to a partner with gonorrhea or chlamydia. At GCHP, urine testing for urethral gonorrhea and chlamydia began in 2011 and was performed by NAAT. We obtained rectal specimens from MSM who reported receptive anal sex in the prior year. At the STD clinic, rectal specimens were tested for gonorrhea and chlamydia using culture until September, 2010 and NAAT thereafter. GCHP used culture for rectal specimens from 2006 to 2007 and began NAAT testing in 2011. GCHP did not test rectal specimens in the period 2008-2010. Our laboratory performed gonorrhea cultures on modified Thayer-Martin media, chlamydia cultures on McCoy cell culture, and NAAT testing using APTIMA Combo 2 (GenProbe Diagnostics, San Diego, CA). All MSM who agreed to give a blood sample were tested for syphilis using the rapid plasma regain test. Most samples were additionally tested using the venereal disease research laboratory (VDRL) test until 2010, at which time VDRL testing was limited to cerebral spinal fluid samples only. A single, experienced disease investigational specialist reviews all cases of syphilis in King County and assigns them a final stage based on laboratory and clinical findings. This information became available in our electronic database beginning in 2006. Before that year, this serology interpretation was not recorded in the medical record, and in some instances records did not include any staging information from a clinical assessment, limiting our ability to definitively identify the syphilis stage of each case. For MSM tested for syphilis before 2006, we defined early syphilis (primary, secondary, or early latent) in this analysis as (1) a clinical diagnosis of early syphilis with a positive rapid plasma regain test and positive Treponema pallidum particle agglutination assay (TPPA), or (2) no clinical syphilis diagnosis recorded, no history of syphilis, and an RPR titer $1:32 with a positive TPPA, or (3) no clinical syphilis diagnosis recorded, no history of syphilis, and a VDRL titer $1:8 with a positive TPPA.
Statistical Analysis
We examined differences in demographic, behavioral and clinical characteristics of patients attending the 2 sites using x 2 tests for categorical variables and t tests for continuous variables. To examine secular trends in sexual behavior, we restricted the analysis to each man's first visit to the STD clinic or GCHP in a calendar year. Thus, no individual could contribute more than 1 visit per year in the behavioral trends analysis, but it is possible that an individual could have 1 visit in each year presented. Because we had STD clinic data for only 3 behavior data were collected through FTFIs) and separate Pvalues for data collected through CASI 2010-2013 (when, on average, 70% of sexual behavior data were collected through CASI). We do not present P-values for linear trends among patients who completed an FTFI in 2011-2013 because that was not the primary method of data collection during that time period. Because of the small number of HIV-positive men attending GCHP, we only used data from the STD clinic to examine behavioral trends among HIV-positive men. We used multivariable log-binomial regression models to estimate the prevalence ratios (PRs) of the associations between sexual behaviors and HIV or bacterial STIs (urethral gonorrhea/chlamydia, rectal gonorrhea/chlamydia, and early syphilis). We present PRs instead of risk ratios because this was a cross-sectional study design; therefore we cannot be certain that behaviors preceded the acquisition of HIV or bacterial STIs. The unit of analysis for regression models was a clinic visit. We clustered by patient, and used robust variances in the regression models to account for multiple visits by the same individual. 28 For the multivariable models we combined 2 sexual behavior categories, "consistent condom use" and "no anal sex" into one category ("no CAI"). Models included the following prespecified confounders of the association between serosorting and HIV/bacterial STIs: age, race/ ethnicity, methamphetamine use (ever/never), clinic, number of male sex partners (past 12 months), calendar year, and time since last HIV test (included in the HIV outcome model only). To evaluate if the absolute risk of HIV associated with serosorting changed over time, we examined secular trends in the proportion of visits where men tested newly positive for HIV (stratified by behavior) and used linear regression to assess the statistical significance of linear trends. Two-sided statistical tests were performed at a significance level (a) of 0.05. This study was reviewed and approved by the University of Washington Institutional Review Board.
RESULTS
During the study period there were 38,192 new problem visits made by 16,718 MSM at the STD clinic, and 18,375 visits made by 10,072 MSM at GCHP. Eighty-nine percent (N = 34,254) of STD clinic visits and 85% of GCHP visits (N = 15,658) had complete behavioral data and were included in this analysis. Men attending the STD clinic were slightly older than men at GCHP (median age 34 vs. 32, respectively) and more likely to report having tested for HIV in the prior 12 months ( Table 1 ). The majority (99%) of GCHP patients were HIV-negative compared with 87% at the STD clinic (Table  1) . Men at the STD clinic more often reported NCCAI (29%) than men at GHCP (22%) but were also more likely to report not having anal sex in the prior year (11% vs. 1%, respectively). The proportion of men testing newly positive for HIV or bacterial STIs was significantly higher at the STD clinic compared with GCHP.
Trends in Serosorting Over Time self-reported being on ART increased from 50% to 83% (P , 0.001); this increase was similar for all HIV-positive MSM regardless of reported sexual behavior (data not shown). Among HIV-negative men at the STD clinic and GCHP who reported NCCAI from 2002 to 2013 (N = 11,536), insertive NCCAI increased significantly (26%-34%; P = 0.001) while receptive NCCAI decreased significantly (67%-60%; P = 0.02). The proportion reporting condom seropositioning was stable (7%-7%; P = 0.15). Using the entire population of HIV-negative MSM as a denominator (N = 44,961), the comparable proportions were 6%-7%, 17%-13%, and 2%-2%, respectively.
Association Between Sexual Behavior and HIV/STIs
Men tested newly positive for HIV at 823 (2.1%) of 38,845 clinic visits (Table 2) . Men who reported serosorting in the prior 12 months had a 47% lower prevalence of testing newly positive for HIV, relative to men reporting NCCAI [adjusted PR (aPR) = 0.53; 95% confidence interval (CI): 0.45 to 0.64], but a 2-fold higher prevalence of testing positive for HIV compared with men who did not have CAI (aPR = 1.98; 95% CI: 1.61 to 2.44). Compared to men who reported NCCAI, HIV-negative men who reported serosorting had a 24% lower prevalence of early syphilis (aPR = 0.76; 95% CI: 0.62 to 0.92) but a similar prevalence of urethral and rectal gonorrhea/chlamydia. Among HIV-positive men, syphilis prevalence was similar for HIV-positive serosorters compared with those who reported NCCAI (aPR = 1.02; 95% CI: 0.81 to 1.30). Serosorting was associated with a significantly higher prevalence of each bacterial STI relative to no CAI for both HIV-negative and HIV-positive men.
Change in the Risk of HIV Associated With Serosorting
From 2002 to 2013, the proportion of men testing newly positive for HIV declined overall from 3.5% to 1.4%. Adjusting for time since last HIV test, we observed declines in the proportion of men testing newly positive for HIV among men who reported NCCAI (P = 0.02), serosorting (P = 0.14) and no CAI (P = 0.01) (Fig. 3) .
DISCUSSION
In this study of nearly 50,000 clinic visits made by MSM over a 12-year period, the proportion of HIV-negative and HIV-positive men who reported serosorting increased substantially, whereas the proportion of HIV-negative men who reported NCCAI declined. Moreover, among HIVnegative men who reported NCCAI, there was a shift toward a larger proportion reporting only insertive NCCAI and a decline in receptive NCCAI. Concurrent with this shift in behavior, the proportion of men testing newly positive for HIV declined for all men regardless of reported sexual behavior. These sentinel surveillance findings suggest that Seattle's MSM population has changed its behavior over the last 12 years to adopt what are generally safer behaviors and that this change in behavior is parallel with a decline in this population's HIV test positivity.
Our findings extend previously observed trends among STD clinic patients in Seattle 10 and indicate that serosorting is the most commonly practiced sexual behavior among MSM at these testing sites. Concurrent with increases in serosorting among HIV-negative MSM, we observed declines in NCCAI and a fairly constant proportion who reported consistent condom use or no anal sex. Taken together, these data suggest that, among HIV-negative MSM, the increase in serosorting likely resulted from a shift in behavior away from NCCAI. Although the change in data collection method at the STD clinic in 2010 and the serial cross-sectional nature of our data limits our ability to draw this conclusion with certainty, there are 2 explanations for the data, which substantiate our interpretations. First, FTFI data through 2010 demonstrate steady increases in serosorting and decreases in NCCAI, which parallels CASI data collected after 2010. Although FTFI data collected after 2010 show inconsistent trends, these data were collected from a subset of MSM who were dissimilar from the larger clinic population in that the majority of men completed a CASI during that time. Second, data from GCHP, where the method of data collection did not change, show steady trends throughout the study period that are similar in magnitude to the STD clinic.
Behavioral trends among HIV-positive men were somewhat dissimilar to those among HIV-negative MSM. Among HIV-positive MSM, there is some suggestion that NCCAI may have increased after 2008, a change that cannot be completely explained by the change in data collection method which occurred in 2010. Unlike among HIV-negative men, we noted relatively large declines in the proportion of HIV-positive men reporting consistent condom use and no anal sex. The reason for these trends among HIV-positive men is unclear but may reflect risk compensation in an era of highly effective and widespread ART use or more accurate reporting over the course of the study period (ie, declines in social desirability bias over time).
Similar to previous studies of sero-adaptive behaviors and HIV risk, 5, 16, 17, 29 we found that serosorting was associated with a 2-fold higher prevalence of testing newly HIV positive compared with no CAI, but a 50% lower prevalence of testing newly HIV positive compared with NCCAI. Thus, our results lend support to public health messaging that promotes consistent condom use as the best risk reduction strategy. 30 At the same time, it is likely that for populations of MSM where HIV testing is common and HIV status disclosure is high, serosorting is an effective HIV prevention strategy among MSM for whom consistent condom use is not achievable. Clinicians and counselors should consider discussing serosorting with their MSM patients who do not consistently use condoms as a potential strategy to be incorporated in a comprehensive HIV riskreduction plan.
Although in no way definitive, we believe that our findings are consistent with the hypothesis that changes in the population's sexual behavior contributed to a decline in new HIV diagnoses. During the 12-year study period, we found that the prevalence of testing newly positive for HIV declined for all MSM. Though the largest absolute reduction in HIV test positivity (7.1%-2.8%) occurred among men reporting NCCAI, the group with the highest risk of HIV infection, the relative reduction in risk was roughly similar across risk groups, varying from 46% among men who serosorted to 61% among men who engaged in NCCAI. These declines may be due to several factors, including an increase in the proportion of HIVinfected MSM in King County who were virologically suppressed 31 or the increase in HIV testing frequency 21 during this period. Regardless of the reason for behaviorspecific declines, the large shift in the population's behavior from NCCAI to serosorting is a compelling factor to consider in the overall decrease in HIV test positivity that we observed. Our findings lend some support to the idea that serosorting may increase the risk of STIs other than HIV. Compared with men who do not engage in CAI, HIVnegative and HIV-positive serosorters had an approximately 30%-100% higher prevalence of all bacterial STIs, a finding that is similar to studies in Chicago, San Francisco, and Australia. 12, 19, 20 At the population-level, the increase in serosorting we observed occurred concurrently with a nearly 3-fold increase in the rate of early syphilis among HIVpositive MSM in King County between 2001 and 2013. 32 This ecological association does not definitively implicate serosorting among HIV-positive MSM as a cause of these rising syphilis rates. However, significant decreases in consistent condom use and no anal sex during the same period, coupled with the higher prevalence of syphilis among serosorters compared with men who did not have CAI (aPR = 1.4; 95% CI: 1.1 to 1.7), support the hypothesis that increases in serosorting may have contributed to the current syphilis epidemic among HIV-positive MSM in Seattle. However, the magnitude of this contribution is uncertain.
This study has a number of strengths. To our knowledge, this is the largest study of serosorting trends in the United States and covers a longer period of time than prior studies. It included 2 MSM populations with different HIV risk profiles. The 2 clinical/testing sites have collected sexual behavior data systematically since the early 2000s and together diagnosed nearly 40% of all new HIV infections among MSM in King County, Washington. We were also able to obtain HIV and STI outcome data, biological measures of serosorting's impact. Our data are also subject to some important limitations. First, this is a cross-sectional study and it is not known if reported behaviors preceded or followed the acquisition of HIV and STIs. Second, we cannot say with certainty if the changes in behaviors we observed reflect true changes in the population's behavior or changes in the composition of the populations from which we collected data. Third, the initiation of the CASI at the STD clinic in 2010 limited our ability to understand how sexual behavior trends truly changed at the clinic. Fourth, our findings are subject to social desirability bias and recall bias. Fifth, multivariable models were adjusted for confounders but imperfect measurement of these factors may have resulted in residual confounding. Sixth, these data represent reported sexual history and do not include behavioral intent; therefore, it is unclear if MSM whose sexual behaviors were consistent with serosorting intended to engage in this behavior as an explicit HIV risk-reducing strategy. Finally, these data are specific to men attending an STD clinic and an HIV/STI testing center in Seattle, and it is not known how these findings may extend to populations outside testing centers or outside Seattle.
In conclusion, we observed significant increases in serosorting, concurrent with declines in NCCAI among Seattle MSM. Given the protective effect of serosorting relative to NCCAI, our findings suggest that serosorting may have contributed to overall declines in HIV incidence in Seattle and highlight how the behavior, though not ideal from a public health perspective, represents a step toward greater safety for some men.
